Evaluation of Patients Treated in Intensıve Care Due to COVID-19: A Retrospective Study

Gökhan Kılınç1, Aslı Akcan Atasoy2

  • 1Department of Anesthesiology and Reanimation Intensive Care, Balıkesir Atatürk City Hospital, Balıkesir, Turkey. gkilinc35@hotmail.com.

Insights

Critically ill patients with COVID-19 pneumonia had a high mortality rate of 69.5%. Older age, high Sequential Organ Failure Assessment (SOFA) scores, elevated d-dimer levels, and diabetes mellitus were associated with increased mortality risk.

Area of Science:

  • Intensive Care Medicine
  • Infectious Diseases
  • Epidemiology

Background:

  • Coronavirus disease 2019 (COVID-19) poses significant challenges in intensive care settings.
  • Understanding factors influencing mortality in critically ill COVID-19 patients is crucial for improving outcomes.

Purpose of the Study:

  • To analyze demographic, clinical, and laboratory factors associated with mortality in intensive care unit (ICU) patients with COVID-19.
  • To identify predictors of death in critically ill COVID-19 patients.

Main Methods:

  • Retrospective cohort study of adult COVID-19 patients in a tertiary hospital ICU.
  • Univariate and multivariate logistic regression analyses were used to identify independent predictors of survival.

Main Results:

  • The overall mortality rate was 69.5% among 200 critically ill COVID-19 patients.
  • Factors significantly associated with increased mortality included older age, higher heart rate, elevated white blood cell counts, high neutrophil/lymphocyte ratio, increased d-dimer, ferritin, C-reactive protein (CRP), APACHE II score, and Sequential Organ Failure Assessment (SOFA) score.
  • Multivariate analysis identified positive reverse transcriptase-polymerase chain reaction (RT-PCR) test, older age, higher heart rate, higher SOFA score, high d-dimer levels at admission, and diabetes mellitus as independent predictors of death.

Conclusions:

  • Critically ill COVID-19 patients exhibit high mortality.
  • Older age, acute respiratory distress syndrome, high SOFA scores, elevated d-dimer levels upon admission, and the presence of diabetes mellitus are associated with increased mortality risk.
Abstract

Related Concept Videos

Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
422
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
341
Acute Respiratory Failure-I01:21

Acute Respiratory Failure-I

Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
299
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
309
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
438
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
40